Pseudorevertants able to use L-leucyl-L-leucyl-L-leucine as a leucine source have been isolated from a Salmonella typhimurium strain carrying stable (nonreverting) mutations in pepN, pepA, and pepB. These strains carry mutations at a locus pto (peptidase T overproducer) tightly linked to pepT that cause an elevated expression of the tripeptidase peptidase T. An F' episome carrying the pto and pepT loci has been constructed and used to show that the pto mutations are cis dominant. Expression of P-galactosidase from a Mu dl(Apr lac) insertion in pepT is increased by pto mutations. The pto mutations, therefore, define a site affecting the transcription of pepT.
Pseudorevertants able to use L-leucyl-L-leucyl-L-leucine as a leucine source have been isolated from a Salmonella typhimurium strain carrying stable (nonreverting) mutations in pepN, pepA, and pepB. These strains carry mutations at a locus pto (peptidase T overproducer) tightly linked to pepT that cause an elevated expression of the tripeptidase peptidase T. An F' episome carrying the pto and pepT loci has been constructed and used to show that the pto mutations are cis dominant. Expression of P-galactosidase from a Mu dl(Apr lac) insertion in pepT is increased by pto mutations. The pto mutations, therefore, define a site affecting the transcription of pepT.
We have isolated mutations affecting several Salmonella typhimurium peptidases and have found that strains lacking certain combinations of these peptidases cannot use many peptides as amino acid sources (11, 16, 18) . It is possible that other genes coding for peptidases have remained undetected because they are not expressed under the growth conditions that we have used or because the peptidases that they encode are specific for peptides that we have not tested. One way to identify such peptidase genes is to isolate mutations that increase their level of expression or that alter the substrate specificity of their gene products. Such mutations might arise as pseudorevertants of multiply peptidasedeficient strains selected for growth on peptides. The problem with this approach has been that reversion of any one of the mutations in known peptidase loci present in a multiply peptidasedeficient strain can restore growth on many peptides. To overcome this problem, we have constructed strains carrying stable (nonreverting) mutations in four pep loci (pepN, pepA, pepB, and pepD) and have attempted to revert such strains to growth on peptides as amino acid sources. This paper describes the isolation and characterization of pseudorevertants that overproduce the aminotripeptidase peptidase T (21) . MATERIALS Media and growth conditions. Standard minimal and rich media have been described previously (21) . When required, minimal media were supplemented with amino acids, peptides, or adenine (0.4 mM), lactose (0.2%), or sorbitol (0.4%). MacConkey-lactose agar (Difco Laboratories) was used for testing lactose fermentation. Green plates (8) were used to test for the presence of phage P22 in bacterial cultures. Plates selective for antibiotic resistance contained tetracycline hydrochloride (Sigma Chemical Co.; 25 ,ug/ml), ampicillin (Sigma; 25 ,ug/ml), or kanamycin sulfate (Sigma; 50 ,ug/ml). Strains containing temperaturesensitive F' lac episomes or Mu dl prophage were incubated at 30°C. All other incubations were at 37°C unless otherwise stated. Peptides. Peptides were purchased from Vega-Fox Biochemicals, Sigma, or Bachem, Inc.
Genetic techniques. Transduction was performed using phage P22 (HT 12/4 int-3) as described by Roth (20) . For transduction to antibiotic resistance, the phage and bacteria were mixed and preincubated at least 30 min before plating on selective medium.
TnOO mutagenesis was performed by the method of Kleckner et al. (13) . TnlO and TnS insertions linked to purB and metE were isolated by standard methods (8, 12) . Strains were made recA by cotransduction with TnlO or Tn5 insertions in the nearby locus srl (utilization of sorbitol as the carbon source). Strains were made purB by cotransduction with linked TnlO or Tn5 insertions.
F' matings were performed by spotting the donor and the recipient together on selective plates or by replica plating donor strains on selective medium spread with 0.2 ml of a recipient culture.
To immobilize Mu dl and allow transduction of the pepl7::Mu dl mutation into different strains, an X mutation (3, 4) TN1214   TN1215   TN1246   TN1298  TN1304   TN1356  TN1358  TN1362  TN1403 through TN1410  TN1412 through TN1419  TN1420  TN1483  TN1507   TN1531   TN1562   TN1594   TN1635  TN1636  TN1642   TN1643   TN1644   TN1668  TT628  TT3256   NK780 A(IeuBCD)485 pepNJO pepAl pepBl zce-850::TnlO pepT+ A(leuBCD)485 pepNJO pepAl pepBl zce-850::TnJO pepTI A(leuBCD)485 pepN9O pepAJ6 pepBlI pepPI pepQI AsupQ302(proAB-pepD) As TN1246 but metE338 zie-822::TnS A(leuBCD)485 pepN90 pepA16 pepBR I pepPi pepQl purBB3 zce-850::TnJO purB13 zce-859::TnS As TN1298 but purBB3 zce-850::TnJO As TN1304 but pto-2 through pto-9 As TN1298 but pto-2 through pto-9 As TN1298 but pepTI As TN1304 but pepTI purB13 zce-859::TnS As TN1304 but pepTI purBB3 zce-859::TnS recA argH88 purBB3 zce-850::TnIOIF'tsl14 zzf- Reversion to growth on peptides. An exponentialphase culture (ca. 108 cells per ml) in appropriately supplemented E medium was concentrated 20-fold, and 0.1 ml was plated in a 2.5-ml soft-agar overlay on an E medium plate containing peptide (0.4 mM), leucine (0.03 mM, a concentration not sufficient to permit full growth), and proline (0.4 mM). Paper disks saturated with diethyl sulfate (Sigma) or N-methyl-N'-nitro-N-nitrosoguanidine (Sigma; 5 mg/ml in 0.01 M citrate buffer, pH 5.5) were placed on the surface of the agar. The above procedure was found to give optimal numbers of revertants and was used to test peptidase mutations for stability, to screen for reversion to peptide growth, and to effect the original isolation of pto mutants. In later experiments, Leu3-utilizing revertants were selected by the following procedure. A sample (0.1 ml) from an overnight nutrient broth culture was plated in 2.5 ml of soft agar on an E medium plate containing 0. 4 A nonreverting pepB mutation was isolated by a double selection for excision of a linked TnlO element and loss of peptidase B activity. Two TnlO insertions were isolated that were linked (34 or 75%) to the pepB locus by P22 transduction. Strains (Tn1242 and TN1243) lacking peptidases N, A, D, P, and Q and containing either of the linked TnlO insertions were plated on a minimal medium described by Bochner et al. (2) that selects for tetracycline-sensitive clones. This medium was supplemented with the toxic peptide norleucylglycylglycine (1.2 mM). Peptidase B hydrolyzes this peptide to release the toxic amino acid analog norleucine (Nle). The peptide is not toxic to peptidase-deficient strains that cannot hydrolyze it. Tets Nle-Gly-Glyr strains were isolated and tested for reversion to growth on the peptide Leu-Leu, a substrate for peptidase B. One nonreverting mutation was identified. This allele, pepBII (strain TN1246), was used for further work.
Characterization of TnlO insertions linked to purB pepT. Four TnlO insertions cotransducible with purB were isolated by standard methods (8) . The location of each insertion with respect to purB and a TnS insertion linked to purB was inferred from two-point cotransduction frequencies. The orientation of each TnlO insertion with respect to the chromosome was determined by the direction of chromosome mobilization by A.
--Io 25 F' lac zzf::TnJO episomes as described by Chumley et al. (6) . F',, lac zzf::TnJO episomes from strains TT627, TT628, and TT629 were introduced into strains carrying the TnlO insertions to be tested and a counterselective marker. Hfr strains were selected on minimal lactose agar at 42°C. The direction of chromosome transfer was inferred from the relative numbers of recombinants in conjugation crosses with pyrD13 and trp-43. The map position of pepT with respect to purB was determined by conjugation of these Hfr strains with a purB trp pepN recipient. Pur+ recombinants were selected, and the linkage of trp and pepN to purB was scored. Details of the characterization of this region of the chromosome have been presented (K. Strauch, Ph.D. thesis, Case Western Reserve University, Cleveland, Ohio, 1982). The information obtained is summarized in Fig. 1 .
Enzyme assays. The presence of peptidase T was tested by a modification of the microtitration plate assay used to isolate pepT mutants (21) . Some strains (TN1562) or cells grown in some media (nutrient broth) gave high levels of background color in this assay. When this was the case, the L-amino acid oxidase-peroxidase-dianisidine solution was not added, and the reaction mixture was deproteinized with 0.1 volume of 50% trichloroacetic acid followed by centrifugation. The supernatant was used for thinlayer electrophoresis as described previously (22), and the reaction products were visualized with ninhydrin. Peptidases were assayed by the trinitrobenzenesulfonate-Cu2" reagent of Binkley et al. (1), using crude extracts prepared from stationary-phase E medium cultures as described previously (21) . Protein concentrations were determined by the method of Lowry et al. (14) with bovine serum albumin (Sigma) as the standard. P-Galactosidase was assayed by the method of Miller (19) .
Gel electrophoresis and stain. Electrophoresis of cell extracts in 7.5% polyacrylamide slab gels and staining for peptidase activity were performed as described previously (18) , except that Tris-hydrochloride buffer (0.2 M; pH 7.5) was used instead of phosphate in the soft-agar gel stain overlay. RESULTS Reversion to growth on leucine peptides. Strains TN1246 and TN1304 were plated on medium containing a variety of peptides as potential leucine sources. The leu(BCD)485 muta- VOL. 156, 1983 on August 27, 2017 by guest http://jb.asm.org/ Downloaded from tion in these strains is a deletion (15) , and the pepN, pepA, and pepB alleles are the stable mutations described above. The pepD mutation in TN1246 is also a deletion [AsupQ(proABpepD)] (10, 17) . Mutations in pepP and pepQ which eliminate two proline-specific peptidases (16) are also present in these strains. These mutations should eliminate the possibility of obtaining specificity change mutations that affect either of these two known enzymes.
Strain TN1246 (leu pepN pepA pepB pepD pepP pepQ) was plated on Leu-Leu, Leu-Trp, Arg-Leu, Met-Leu, Pro-Leu, Leu-Gly, LysLeu, or Leu-Ala-NH2. No revertants able to grow on these leucine sources were obtained. This result suggests that peptidases N, A, B, and D may account for nearly the total complement of hydrolytic activity toward many dipeptides.
Strain TN1304 (leu pepN pepA pepB pepP pepQ pepD+) was plated on Leu3 or Gly-LeuLeu-Gly as a leucine source. We expected that peptidase D (a dipeptidase) would aid in the catabolism of dipeptides that might be generated by cleavage of the larger substrates. Mutants that utilized Leu3 were isolated after 2 to 3 days of incubation. Small, flat colonies were apparent on the Gly-Leu-Leu-Gly plates only after 2 weeks of incubation. After single-colony purification on nonselective medium, the mutants were retested for the ability to use the peptides Leu3 and Gly-Leu-Leu-Gly. All mutants, regardless of the peptide on which they had been selected, showed strong growth on Leu3 and weak growth on Gly-Leu-Leu-Gly. Growth on Gly-Leu-Leu-Gly occurred in a narrow zone around peptide crystals, and there did not appear to be any difference between the parent and mutant strains. However, because these mutant strains differed from the parent strain in their ability to grow on Leu3, they were kept for analysis. Four mutants selected on Leu3 (TN1403 through TN1406) and four mutants selected on Gly-Leu-Leu-Gly (TN1407 through TN1410) were saved.
Mapping of mutations that permit growth on LeU3. The parent strain TN1304 contained peptidase T, a tripeptidase. Mutations (pepT) eliminating this tripeptidase have been isolated, mapped, and found not to affect the utilization as amino acid sources of any tripeptidases which peptidase T is known to hydrolyze in vitro (21) .
We suspected that the Leu3-utilizing mutants might overproduce peptidase T and therefore tested for linkage between pepT and the mutations responsible for growth on Leu3. This was done by transducing the mutants to Tetr with phage grown on strains containing a TnJO insertion 75% linked to pepT+ (strain TN1214). The Tetr transductants were scored for growth on Leu3. All mutants gave some fraction (60 to 90%) of Tetr transductants that could no longer grow on Leu3. Therefore, the mutations conferring the ability to grow on Leu3 mapped near the pepT locus.
We wished to move the mutations out of their mutagenized backgrounds before they were further characterized. The pepT locus is cotransducible with purB at ca. 25 map units on the S. typhimurium map (21) . Transducing phage grown on the Leu3-utilizing mutants was used to transduce TN1362 [leu metE purB pepN pepA pepB pepP pepQ AsupQ(proAB-pepD)] to Pur+. To identify transductants carrying the putative overproducer mutation, purified Pur+ colonies were tested for growth on Leu3 and Met-GlyGly. Both of these peptides are peptidase T substrates, but neither is used by a strain carrying a wild-type pepT region (e.g., TN1298). Crosses involving donor strains originally isolated on Gly-Leu-Leu-Gly yielded Pur+ transductants that utilized both Met-Gly-Gly (as a methionine source) and Leu3 (as a leucine source). Crosses using strains originally isolated on Leu3 gave Pur+ transductants that used Met-Gly-Gly but not Leu3. (The linkage of the altered peptide utilization to purB was approximately 70% ir. all crosses.) We hypothesized that the Gly-LeuLeu-Gly-selected mutants might contain higher levels of peptidase T than do those isolated on Leu3. If so, the growth on Leu3 of the strains originally isolated on Leu3 might require peptidase D (to hydrolyze Leu2 produced by peptidase T), and transfer of the mutations to a strain lacking peptidase D (such as TN1362) might lead to a loss of Leu3 utilization. To test this, one Met-Gly-Gly-utilizing, Leu3-nonutilizing transductant from each cross was made pepD+ by transduction. In each case, the pepD+ derivative utilized Leu3. Therefore, the mutations that confer the ability to grow on Leu3 are present in the isogenic set of strains TN1412 through TN1419.
Peptidase activity in Leu3-utilizing strains. Peptidase T is usually observed at an Rf of 0.2 after electrophoresis of cell extracts in nondenaturing polyacrylamide gels, although occasionally activity can also be observed at an Rf of 0.4 (21) . The activity at an Rf of 0.4 can also be seen in column eluents after DEAE-cellulose chromatography of crude extracts containing only the activity at an Rf of 0.2 (21) . Crude extracts ofpto mutants (strains TN1412 through TN1419) were prepared and electrophoresed in polyacrylamide gels which were stained for activity with MetAla-Ser, Met-Thr-Met, Leu3, and Met-Gly-Gly. All of the extracts of pto strains contained substantially increased levels of peptidase activity toward all of these substrates in the region of the gel where peptidase T migrates (Rf, 0. either a smear of activity or what appeared to be multiple bands in this region, whereas the wild type (TN1298) produced only a single band at an Rf of 0.2. Because no peptidase activity whatever was observed in this region when an extract of TN1644 (pto-7 pepT7::Mu dl) was tested, we believe that the multiple bands probably represented electrophoretic forms of peptidase T.
Assays of peptidase activity in crude extracts showed that all of the strains containing pto mutations contained ca. 5-to 18-fold-elevated activity toward the peptides Met-Gly-Gly (Table  2) , Met-Met-Met, and Leu3 (data not shown). Note that strains isolated on Gly-Leu-Leu-Gly contained two to three times more activity than did those isolated on Leu3. For each strain, the tripeptidase activity toward all three tripeptides tested was elevated to approximately the same extent. Therefore, it is unlikely that the mutations result in specificity changes in peptidase T. In mixed-extract assays, neither the wild-type (pepT+) nor mutant (pepTl) extracts inhibited the tripeptidase activity of the Leu3-utilizing mutant strains (data not shown), which indicates that an inhibitor of peptidase T is not inactivated by these mutations. This evidence, as well as the results presented below, indicates that the increased activity is due to overproduction of peptidase T, and the mutations have therefore been named pto (peptidase T overproducer).
Growth ofpto strains on peptides. The isogenic set of strains TN1412 through TN1419 was used to test the effect of the pto mutations on the utilization of a variety of peptides as leucine, proline, or methionine sources ( Table 3 ). The pto mutations did not enable the cell to use any of the dipeptides, tetrapeptides, or the tripeptide amide tested as amino acid sources. The pto strains were able to use most of the tripeptides which were tested. This pattern of peptide use is consistent with the proposal that the enzyme which has been affected by the pto mutations is a tripeptidase.
Although the mutations pto-6, pto-7, pto-8, and pto-9 were isolated on Gly-Leu-Leu-Gly, these mutations did not permit better utilization of this peptide (Table 3) . It is not likely that elevated levels of peptidase T, a tripeptidase, could enable the cell to use Gly-Leu-Leu-Gly as a source of leucine. It is possible that the original Gly-Leu-Leu-Gly-utilizing mutants contained two mutations: one that allowed hydrolysis of this peptide to an amino acid and a tripeptide (Gly plus Leu-Leu-Gly or Gly-Leu-Leu plus Gly) and another that allowed the hydrolysis of the tripeptide. If the tripeptide was a relatively poor substrate for peptidase T, then very high tripeptidase levels may have been necessary for sufficient hydrolysis of this peptide to permit growth. This would explain why the mutations selected on Gly-Leu-Leu-Gly allowed more efficient growth on tripeptides than did the mutations selected on Leu3. The toxicity of Gly-LeuLeu-Gly and the very poor growth of the originally selected mutants make analysis of this problem difficult, and it has not been pursued.
Linkage of pto to pepT. To map the pto mutations more accurately, the linkage between pto and pepT was determined. Because the wildtype pepT locus does not confer a peptide utilization phenotype on the cell (21), pepT+ cannot be selected in a cross, but it can be scored by enzyme assay. A transduction cross between TN1408 (pto-7) as the donor and TN1483 (purB13 pepTl) was performed, with selection for Pur+. Transductants were scored for pepT by enzyme assay (hydrolysis of Met-Ala-Ser) and for pto by growth on Leu3. Of c TN1412 through TN1415: pto-2 through pto-5 (selected on LeU3). d TN1416 through TN1420: pto-6 through pto-9 (selected on Gly-Leu-Leu-Gly).
'TN1420: pepTi. f These strains show strong growth on Leu3 when made pepD+. control. TN1304 gave many large colonies that grew on Leu3 after 2 days of incubation. Three of the pepT transductants gave large colonies on the plates after 4 days of incubation. The rest of the transductants showed only microcolonies at this time. The three transductants that could mutate to growth on Leu3 and one transductant that could not were used as donors in transductional crosses to determine whether they carried a pto mutation. Phage grown on these strains was used to transduce TN1304 (pto+ pepT+) and TN1345 (pto+ pepTI) to growth on Leu3. Two of the transductants that mutated to growth on Leu3 could transduce TN1304 (pto+ pepT) to growth on Leu3 but could not transduce TN1345 (pto+ pepTl) to growth on Leu3. (No Leu3-utilizing transductants were expected from TN1345 because this strain carries the pepTI mutation also present in both donors.) The other two transductants were not able to transduce either recipient to growth on Leu3. Therefore, two transductants that were genotypically pto-7 pepTl were identified. Because these strains are clearly pto but do not grow on Leu3, the pto mutation alone is not sufficient for growth on Leu3; the pepT+ allele is also required. If the reversion screen was efficient in identifying pto pepT strains, then we can estimate that, among the 138 pepT transductants from the cross described above, no more than four pto pepT transductants should have occurred. This would make the pto pepT class the minority class in this cross, which would indicate that pto-7 lies on the purB distal side of pepTI and that the probable gene order is pto-pepT-purB.
Construction of an F' purB pepT episome. To perform dominance and cis-trans tests on the pto mutations, an F' episome carrying the purBpepT region was constructed by using a method for isolating translocations of segments of the bacterial chromosome described by Chumley and Roth (7) . The general strategy of this con- struction is shown in Fig. 2 . Two TnlO insertions flanking the purB-pepT region can generate unequal crossing over during a transductional cross to give a duplication of purB pepT with a TnJO element at the join point. Homologous recombination between the duplicated regions can then form a small circular fragment containing purB, pepT, and a TnJO element. Homologous recombination between this TnJO and a TnlO insertion on an F' lac episome can then form an F' episome of the structure shown in Fig. 2 .
TnlO insertions flanking purB and pepT were isolated as described above. To construct the F' lac purB pepT episome, a transductional cross between phage grown on strain TN1492 (zee-863::TnJO) and strain TN1531 (argH88 purB13 zce-850::TnJO/F'ts,14 lac zzf-21::TnJO) was performed, with selection for Pur+. One hundred Pur+ transductants were purified and tested for the presence of an F' purB episome by replica plating to a lawn of TN1507 (purB leu pepN pepA pepB pepP pepQ recA) on minimal medium containing leucine (which selects for Pur+ and counterselects the Arg requirement of the transductants). One strain was recovered which could transfer Pur+ to TN1507. (Because this strain was recA+, it was not expected to be stable and was not saved. However, this strain did segregate Pur-Tets Lac-colonies at 42°C, indicating that it contained an F' episome formed by the mechanism shown in Fig. 2 rather than by the alternate mechanism discussed by Chumley and Roth [7] .) The Pur+ derivative of TN1507 was saved as TN1562. This strain was from a pepT gene located in cis with the pto mutation.
pepT::lac operon fusions. Because the pto mutatiens were found to be cis dominant, it seemed likely that they affect a site involved in the transcription of pepT. To test this, the effect of pto on a pepT::lac operon fusion was examined. The isolation of Mu dl(Apr lac) (5) insertions into pepT has been described previously (21 (Table 5 ). To show that the pto mutation was present in class II transductants, phage grown on these transductants was used to transduce TN1304 (pepT+ pto+) to Tetr. A fraction (12 of 52) of the Tetr transductants were able to use Leu3 as a leucine source. The class II transductants must therefore carry a pto mutation. The ability of the pto mutation to affect expression of the Lac phenotype indicates that the pto mutations act at the level of transcription.
An isogenic set of strains was constructed to test the effect of all of the pto mutations on the expression of ,B-galactosidase. This was done by transducing strain LT2 to Ampr with phage grown on TN1644. (The X mutation in this strain immobilizes the Mu dl prophage and allows it to be transduced into other strains without zygotic induction.) An Ampr colony with the fisheye Lac phenotype was saved as strain TN1668. Gel electrophoresis of cell extracts and staining for Met-Ala-Ser, Met-Ala-Met, and Met-Gly-Gly hydrolysis confirmed that peptidase T was absent in this strain. The various pto mutations were introduced into TN1668 by cotransduction with a TnJO insertion linked to pto. These crosses were carried out on MacConkey-lactose-tetracycline medium so that pto pepT::lac transductants could be identified as uniformly red colonies. All of the donor strains yielded such transductants (20 to 35% of all Lac' Tetr transductants). A transductant from each cross was shown to carry a pto mutation by the backcross to TN1304 described above. All pto mutations elevated ,-galactosidase activity by ca. 13-fold (Table 6 ).
DISCUSSION
We have described the isolation of nonreverting mutations that eliminate peptidases N, A, and B. Strains carrying these three mutations and a deletion of the pepD locus do not revert to growth on several leucine-containing dipeptides. This suggests that S. typhimurium does not contain any cryptic peptidase activity which could acquire activity against these dipeptides as a result of mutation.
Pseudorevertants that utilize the tripeptide Leu3 were easily isolated. These mutants regain the ability to utilize a variety of tripeptides as amino acid sources but do not use dipeptides or tetrapeptides. This paper shows that the mutations (pto) present in these strains result in the overproduction of peptidase T. The pto mutations are tightly linked to pepT, the gene for peptidase T; they are cis dominant; and they We have reported that pepTr strains fail to utilize most of the substrates which peptidase T is known to hydrolyze in vitro (21) . In addition, isogenic pepT mutants are still able to use the few tripeptides which are utilized by pepT+ strains, suggesting that another peptidase was responsible for utilization of those tripeptides (21) . These observations suggested that peptidase T is not involved in peptide catabolism, but this paper shows that peptidase T can function in peptide catabolism if present in a sufficient amount. The failure of wild-type levels of peptidase T to permit growth on peptides raises the possibility that the enzyme is regulated such that it is repressed under the growth conditions tested. Evidence that peptidase T is regulated will be presented in another communication (K. L. Strauch and C. G. Miller, manuscript in preparation).
The strains selected on Gly-Leu-Leu-Gly contained higher levels of peptidase T than did those isolated on Leu3. However, the pto mutations recovered from the Gly-Leu-Leu-Gly-selected strains had the same effect on p-galactosidase levels in the lac fusion strains as did pto mutations from strains isolated on Leu3. The most likely explanation of this finding is that the strains isolated on Gly-Leu-Leu-Gly contain an additional mutation that leads to increased peptidase T activity but does not affect transcription of the pepT gene. The nature of these postulated secondary mutations has not been investigated. Because Leu3-selected mutants cannot use this peptide when peptidase D is missing, but the Gly-Leu-Leu-Gly-selected mutants can use Leu3 in the absence of peptidase D, it should be possible to select these secondary mutations by requiring a pto pepT' pepD strain to use Leu3 as a leucine source. This work demonstrates the usefulness of nonreverting mutations and selection for pseudorevertants in the isolation of overproducer mutants. To our knowledge, this is the first case of the overproduction of a peptidase due to mutation. By use of the stable mutations and appropriate strains containing only one peptidase, it should be possible to isolate overproducer mutants or specificity change mutants for any peptidase, provided one can identify a peptide hydrolyzed too slowly by the wild-type enzyme to allow growth.
